Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-07-29
2008-11-25
Tucker, Zachary C (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S357000
Reexamination Certificate
active
07456180
ABSTRACT:
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): where G, J, L, M, x, y, W, V, R2, R3, R4, R5, R6, R7, R8, R8a, R9, R9a, R10, R10a, R11and R11a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
REFERENCES:
patent: 4959368 (1990-09-01), Awaya et al.
patent: 23 41 925 (1975-03-01), None
patent: WO-01/62954 (2001-08-01), None
patent: WO-01/96327 (2001-12-01), None
patent: WO-02/10154 (2002-02-01), None
patent: WO-03/075929 (2003-09-01), None
patent: WO-03/091247 (2003-11-01), None
Ntambi & Miyazaki “Recent insights into stearoyl-CoA desaturates-1” Current Opionion in Llpidology, vol. 14, pp. 255-261 (2003).
Gotor V. et al. “Fungal and Bacterial Regioselective Hydroxylation of Pyrimidine Heterocycles”, Tetrahedron, Elsevier Science Publishers, Amsterdam, NL, vol. 53, No. 18, (May 5, 1997), pp. 6421-6432.
International Search Report for PCT/US2004/024658, published Feb. 2, 2005 (4 pages).
Official Action issued Jul. 14, 2008, by the Canadian Intellectual Property Office in related Canadian Application No. 2,533,901 (references cited therein previously filed with this application on Jan. 30, 2006) (3 pages).
Abreo Melwyn
Gschwend Heinz W.
Holladay Mark W.
Kamboj Rajender
Kodumuru Vishnumurthy
Osha & Liang LLP
Tucker Zachary C
Xenon Pharmaceuticals Inc.
LandOfFree
Piperazine derivatives and their use as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine derivatives and their use as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives and their use as therapeutic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4022395